Beyond paracetamol, Farmson has emerged as a world-class manufacturer of Caffeine API, leveraging decades of expertise in chemical synthesis. The company has built a state-of-the-art facility dedicated to synthetic caffeine production, serving industries from pharmaceuticals to food and beverage. This forward integration into caffeine manufacturing aligns with Farmson’s long-term vision to broaden India’s role as a reliable source of high-quality APIs. The caffeine plant is designed with cutting-edge technology and strict quality protocols, ensuring that pharmaceutical-grade caffeine (anhydrous) meets the highest purity standards required by global markets.

Farmson’s caffeine production process exemplifies precision engineering and rigorous quality control. It employs a seven-stage chemical conversion process, which allows exceptional control over impurities in the final product. During manufacturing, four key intermediates are isolated and monitored, enabling the early removal of impurities and preventing their carryover. The result is a high-purity caffeine API with minimal contaminants. Farmson meticulously controls potential genotoxic and nitrosamine impurities at every step, and adheres to validated cleaning procedures per USFDA/EU GMP guidelines to prevent cross-contamination. Thanks to these measures, Farmson’s caffeine meets major pharmacopoeial standards (IP, EP/BP, USP, JP) and is produced in the stable Form-II polymorph for consistent quality.

Key features of Farmson’s caffeine manufacturing approach include:

• Quality: The caffeine API consistently meets the highest pharmaceutical and food-grade quality standards. Every batch undergoes stringent testing to ensure purity and potency.
  
• Efficiency: Advanced process engineering and scale allow cost-effective production and reliable supply. The facility is capable of producing ~300 metric tons of caffeine per month, with scalability up to 600 MT/month to meet growing demand.
  
• Compliance: The entire operation complies with international regulatory frameworks. Farmson is preparing filings for US DMF and a CEP (Certificate of European Pharmacopoeia) for its caffeine API, underscoring its commitment to global regulatory standards.
  

With its modern caffeine plant, Farmson serves a broad range of applications – from energy drinks and soft beverages to pharmaceuticals – by delivering a caffeine API that is high-purity, consistent, and trusted worldwide. The investment in seven-step synthesis and extensive quality assurance demonstrates how well-versed Farmson is in caffeine manufacturing excellence. By combining innovation with stringent quality control, Farmson has positioned itself as a reliable partner for caffeine API, ensuring a dependable supply of this critical stimulant for formulators around the globe.